Chris Pasquale
Stock Analyst at Guggenheim
(n/a)
# 4,476
Out of 4,479 analysts
6
Total ratings
n/a
Success rate
-28.27%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZIMV ZimVie | Initiates: Neutral | n/a | $18.14 | - | 1 | Mar 18, 2022 | |
| ICAD iCAD, Inc. | Downgrades: Neutral | n/a | $1.19 | - | 2 | Jan 18, 2022 | |
| DXCM DexCom | Upgrades: Buy | $145 | $112.49 | +28.90% | 1 | Jan 7, 2022 | |
| COO The Cooper Companies | Upgrades: Buy | $124 | $86.51 | +43.05% | 1 | Jan 3, 2022 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | n/a | $63.16 | - | 1 | Oct 11, 2021 |
ZimVie
Mar 18, 2022
Initiates: Neutral
Price Target: n/a
Current: $18.14
Upside: -
iCAD, Inc.
Jan 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $112.49
Upside: +28.90%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $86.51
Upside: +43.05%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: n/a
Current: $63.16
Upside: -